@ccvolk.bsky.social teaching us about TDM of dapto, dalba, and orita @sidpharm.bsky.social @escmid.bsky.social PK/PD conference! 🔑 Consider flat based dosing of dapto 🔑 You may be able to extend abx coverage duration by 2 wks by giving 1.5g dalba x2 but 21 days apart 🔑Orita: still limited data

Honored to have been part of this amazing event! Can’t thank the organizers enough for all the work they put in to make this such a valuable experience! @sidpharm.bsky.social @escmid.bsky.social

Be sure to join Dr. @ccvolk.bsky.social as she shares her team's experience with long term dalbavancin use & PK estimates at #ESCMIDGlobal 2025! Monthly dosing of dalbavancin for suppression supported by both PK modeling & a case series showing no treatment failure or infection recurrence 💉

it’s the happiest Thursday because @sidpharm.bsky.social and the @escmid.bsky.social PK PD study group are bringing back ICAAC (in spirit)!!!! Registration will open next week! The Midwest in the summer is magical - come join us! sidp.org/page-1543694 #idsky #amssky #pharmsky